Top

Infection

Published in:

01-10-2020 | Coronavirus | Original Paper

Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China

Authors: Hong Zhang, Wenli Shang, Qinghua Liu, Xuejing Zhang, Maochuan Zheng, Maokui Yue

Published in: Infection | Issue 5/2020

Abstract

Purpose

We aimed to report the clinical characteristics of 194 cases coronavirus disease-19 (COVID-19) in Huanggang, Hubei and Taian, Shandong.

Methods

We retrospectively investigated the clinical, laboratory characteristics and CT imaging of confirmed cases of COVID-19 from January 22 to February 28, 2020 in Huanggang Central Hospital and The Second Affiliated Hospital of Shandong First Medical University. Real time PCR was used to detect the new coronavirus in respiratory samples. Immunohistochemical staining was used to detect the expressions of ACE2 in tissues.

Results

Among the 194 patients infected with COVID-19, 108 patients were male, with a median age of 48.3 years. The average preclinical period was 7.44 day. Except for 37 severe or critically ill patients, the rest of the 157 patients exhibited mild or moderate symptoms. 190 (97.94%) patients were confirmed during the three times nucleic acid test. The main clinical symptom of the patients were fever, sore throat and cough, which accounted for 146 cases (75.26%), 98 (50.52%) and 86 cases (44.33%), respectively. 30 patients (15.46%) showed liver dysfunction. Imaging examination showed that 141 patients (72.68%) showed abnormal density shadow, while 53 cases (27.32%) had no obvious abnormality in the parenchyma of both lungs. Up to now, 109 cases have been discharged from the hospital, and 9 patients died. The ACE2 expression levels were up-regulated in patients of severe type and critically ill type.

Conclusion

Clinical symptoms, laboratory tests and CT imaging should be combined for comprehensive analysis to diagnose COVID-19. ACE2 may be the receptor of COVID-19.

Available only for authorised users

Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214–7. https://doi.org/10.1016/j.ijid.2020.01.050.CrossRefPubMedPubMedCentral

Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3. https://doi.org/10.1038/s41586-020-2012-7.CrossRefPubMedPubMedCentral

Lillie PJ, Samson A, Li A, et al. Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.020.CrossRefPubMedPubMedCentral

Lim J, Jeon S, Shin HY, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 2020;35:e79. https://doi.org/10.3346/jkms.2020.35.e79.CrossRefPubMedPubMedCentral

Nishiura H. Backcalculating the incidence of infection with COVID-19 on the diamond princess. J Clin Med. 2020. https://doi.org/10.3390/jcm9030657.CrossRefPubMedPubMedCentral

Zhang Y, Xu J, Li H, Cao B. A novel coronavirus (COVID-19) outbreak: A call for action. Chest. 2020. https://doi.org/10.1016/j.chest.2020.02.014.CrossRefPubMedPubMedCentral

Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.018.CrossRefPubMedPubMedCentral

Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa199.CrossRefPubMedPubMedCentral

Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.017.CrossRefPubMedPubMedCentral

10.

Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.016.CrossRefPubMedPubMedCentral

11.

Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164. https://doi.org/10.1016/B978-0-12-385885-6.00009-2.CrossRefPubMedPubMedCentral

12.

Brian DA, Baric RS. Coronavirus genome structure and replication. In: Enjuanes L, editor. Coronavirus replication and reverse genetics. Current topics in microbiology and immunology, vol 287. Berlin, Heidelberg: Springer; 2005.

13.

Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet. 2020;395:542–5. https://doi.org/10.1016/S0140-6736(20)30374-3.CrossRefPubMedPubMedCentral

14.

Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–74. https://doi.org/10.1016/S0140-6736(20)30251-8.CrossRefPubMedPubMedCentral

15.

Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200:282–9.PubMedPubMedCentral

16.

Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–94.PubMed

17.

Parashar UD, Anderson LJ. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol. 2004;33:628–34.PubMed

18.

Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020. https://doi.org/10.1007/s12519-020-00345-5.CrossRefPubMedPubMedCentral

19.

Yang F, Liu N, Wu JY, Hu LL, Su GS, Zheng NS. Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV). Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E004. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0004.CrossRefPubMed

20.

Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–72.PubMedPubMedCentral

21.

Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875–9. https://doi.org/10.1038/nm1267.CrossRefPubMedPubMedCentral

22.

Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020. https://doi.org/10.1016/j.cell.2020.02.052.CrossRefPubMedPubMedCentral

Title: Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China
Authors: Hong Zhang
Wenli Shang
Qinghua Liu
Xuejing Zhang
Maochuan Zheng
Maokui Yue
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Coronavirus
Severe Acute Respiratory Syndrome Coronavirus
Pneumonia
COVID-19
Sore Throat
Published in: Infection / Issue 5/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-020-01440-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2020

Abiotrophia defectiva as a cause of infective endocarditis with embolic complications in children

Correction to: Voriconazole-induced periostitis in stem cell transplant patient

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights

Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient

Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials